Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Wen H, Wang HY, He X, Wu CI. On the low reproducibility of most cancers research. Natl Sci Rev. 2018;5:619–24. https://doi.org/10.1093/nsr/nwy021Article
...
Immutep Ltd (AU:IMM) has launched an replace.
Immutep Ltd has acquired optimistic suggestions from the FDA for his or her upcoming Section III trial,...
